I disagree with their opinion that other trials won't begin until early to mid 2025. Unless I'm missing something, with over $26m in the bank, I see no reason for further delays other than getting FDA's approval on the protocol(s).

Quote:

---

Mid to late fall is when the earliest of the results of the studies could be appreciated while other trials won't begin until early to mid 2025.

---